With the analysis among 39 patents, we discovered top 13 key players by total patent application. Triphase Research & Development I Corp, Millennium Pharmaceuticals, Inc., Eutropics Pharmaceuticals, Inc. are dominant in this area. They take 94.87% of the total patent filing.
British Columbia, Canada
Patent: 12
Massachusetts, United States
Patent: 8
Massachusetts, United States
Patent: 3
Neuchâtel, Switzerland
Patent: 3
Glaxosmithkline Intellectual Property Development Ltd.
East Sussex, United Kingdom
Patent: 2
New Jersey, United States
Patent: 1
EDINBURGH, United Kingdom
Patent: 1
California, United States
Patent: 1
Kanagawa-ken, Japan
Patent: 1
No data, please try another search term
With the analysis among related 3 patents applied in the last 5 years. We discover 4 most active companies in this area. The fast-growing Glaxosmithkline Intellectual Property Development Ltd., Celgene International II SARL, Triphase Research & Development I Corp take 133.33% of patent filing during this period.
Glaxosmithkline Intellectual Property Development Ltd.
East Sussex, United Kingdom
Patent: 2
Neuchâtel, Switzerland
Patent: 1
British Columbia, Canada
Patent: 1
Massachusetts, United States
Patent: 1
With the analysis among related 3 patents in last 5 years, we discover 1 new entrants.
Glaxosmithkline Intellectual Property Development Ltd.
East Sussex, United Kingdom
Patent: 2
With the analysis among 9 patents, we discovered top 3 universities and scientific research institutions by total patent application.
Castilla y León, Spain
Patent: 2
New York, United States
Patent: 1